1. Home
  2. KMT vs LQDA Comparison

KMT vs LQDA Comparison

Compare KMT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$29.20

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$34.26

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
LQDA
Founded
1938
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
KMT
LQDA
Price
$29.20
$34.26
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$25.83
$37.40
AVG Volume (30 Days)
809.0K
1.7M
Earning Date
02-04-2026
11-03-2025
Dividend Yield
2.73%
N/A
EPS Growth
N/A
N/A
EPS
1.22
N/A
Revenue
$1,982,871,000.00
$69,216,000.00
Revenue This Year
$7.69
$904.79
Revenue Next Year
$3.82
$188.25
P/E Ratio
$24.03
N/A
Revenue Growth
N/A
343.41
52 Week Low
$17.30
$10.37
52 Week High
$29.89
$35.54

Technical Indicators

Market Signals
Indicator
KMT
LQDA
Relative Strength Index (RSI) 70.35 64.53
Support Level $27.47 $32.11
Resistance Level $29.89 $35.54
Average True Range (ATR) 0.58 1.55
MACD 0.04 -0.10
Stochastic Oscillator 74.80 76.90

Price Performance

Historical Comparison
KMT
LQDA

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: